Mobile App Logging for Diabetes in Pregnancy
Gestational Diabetes Mellitus in Pregnancy, Type 2 Diabetes
About this trial
This is an interventional treatment trial for Gestational Diabetes Mellitus in Pregnancy focused on measuring technology in medicine, mobile applications, blood glucose monitoring, diabetes in pregnancy
Eligibility Criteria
Inclusion Criteria: 18 years and older Verified intrauterine pregnancy At least 12 weeks gestation Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus. Exclusion Criteria: Patients with less than 4 weeks anticipated to be remaining in pregnancy Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking Type 1 diabetes mellitus Non-English speaking patients
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Mobile App arm
Paper Log Arm
Patient will input their daily blood glucose levels (fasting and 2 hours after breakfast, lunch and dinner) into the OneTouch Reveal app
Patients will input their daily blood glucose levels onto paper logs which is the current process in the prenatal clinic.